LADENBURG THALMANN FINANCIAL SERVICES INC. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 41 filers reported holding CTI BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2019$2,0001,110
+5450.0%
0.00%
Q3 2019$0200.0%0.00%
Q2 2019$0200.0%0.00%
Q1 2019$0200.0%0.00%
Q4 2018$0200.0%0.00%
Q3 2018$0200.0%0.00%
Q2 2018$0200.0%0.00%
Q1 2018$0200.0%0.00%
Q4 2017$0200.0%0.00%
Q3 2017$020
-83.3%
0.00%
Q2 2017$0
-100.0%
1200.0%0.00%
Q1 2017$1,0001200.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders